Sign in
4

Changes in Ownership

Protara Therapeutics, Inc. Filed Acc 0001209191-21-004653

Options or other derivatives

  • Chief Financial Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Davis Blaine · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-19 Grant or award : show line 1 in the form Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X03/doc4.xml…